Technology
Here’s Why Pfizer and BioNTech Are Selling Their Vaccine at Cost – Motley Fool
The humanitarian move might help the companies gain additional for-profit contracts in the future.
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently agreed to sell their COVID-19 vaccine to the U.S. government at cost. In this video from Motley Fool Live, recorded on June 14, Fool.com contributors Brian Orelli and Keith Speights discuss why the companies…
Continue Reading
-
General12 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News15 hours agoSanta drops in for carols
-
General17 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Business16 hours agoHow much upside does Macquarie predict for Sonic Healthcare shares?